Literature DB >> 22723411

Evolution, safety, and highly pathogenic influenza viruses.

Marc Lipsitch1, Joshua B Plotkin, Lone Simonsen, Barry Bloom.   

Abstract

Experience with influenza has shown that predictions of virus phenotype or fitness from nucleotide sequence are imperfect and that predicting the timing and course of evolution is extremely difficult. Such uncertainty means that the risk of experiments with mammalian-transmissible, possibly highly virulent influenza viruses remains high even if some aspects of their laboratory biology are reassuring; it also implies limitations on the ability of laboratory observations to guide interpretation of surveillance of strains in the field. Thus, we propose that future experiments with virulent pathogens whose accidental or deliberate release could lead to extensive spread in human populations should be limited by explicit risk-benefit considerations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723411      PMCID: PMC3467308          DOI: 10.1126/science.1223204

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Avian influenza. Surprising twist in debate over lab-made H5N1.

Authors:  Jon Cohen
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

Authors:  Rick A Bright; Marie-jo Medina; Xiyan Xu; Gilda Perez-Oronoz; Teresa R Wallis; Xiaohong M Davis; Laura Povinelli; Nancy J Cox; Alexander I Klimov
Journal:  Lancet       Date:  2005-09-22       Impact factor: 79.321

4.  Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

Authors:  Maki Kiso; Keiko Mitamura; Yuko Sakai-Tagawa; Kyoko Shiraishi; Chiharu Kawakami; Kazuhiro Kimura; Frederick G Hayden; Norio Sugaya; Yoshihiro Kawaoka
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

5.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

6.  Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus.

Authors:  Joshua B Plotkin; Jonathan Dushoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

7.  Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.

Authors:  C Sweet; F G Hayden; K J Jakeman; S Grambas; A J Hay
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

Review 8.  Smallpox and bioterrorism.

Authors:  Hugh Pennington
Journal:  Bull World Health Organ       Date:  2003-11-25       Impact factor: 9.408

9.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

Authors:  F G Hayden; R B Belshe; R D Clover; A J Hay; M G Oakes; W Soo
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

10.  Prevalence of epistasis in the evolution of influenza A surface proteins.

Authors:  Sergey Kryazhimskiy; Jonathan Dushoff; Georgii A Bazykin; Joshua B Plotkin
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917

View more
  18 in total

1.  Freeze on mutant-flu research set to thaw.

Authors:  Declan Butler
Journal:  Nature       Date:  2012-06-26       Impact factor: 49.962

Review 2.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

3.  The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.

Authors:  Nicholas Greig Evans; Marc Lipsitch; Meira Levinson
Journal:  J Med Ethics       Date:  2015-08-28       Impact factor: 2.903

4.  H5N1 avian flu research and the ethics of knowledge.

Authors:  David B Resnik
Journal:  Hastings Cent Rep       Date:  2013-02-06       Impact factor: 2.683

5.  Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.

Authors:  Roberto Gasparini; Paolo Bonanni; Daniela Amicizia; Antonino Bella; Isabella Donatelli; Maria Luisa Cristina; Donatella Panatto; Piero Luigi Lai
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

6.  Ethical alternatives to experiments with novel potential pandemic pathogens.

Authors:  Marc Lipsitch; Alison P Galvani
Journal:  PLoS Med       Date:  2014-05-20       Impact factor: 11.069

7.  Rethinking biosafety in research on potential pandemic pathogens.

Authors:  Marc Lipsitch; Barry R Bloom
Journal:  MBio       Date:  2012-10-09       Impact factor: 7.867

8.  The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.

Authors:  Benjamin M Althouse; Oscar Patterson-Lomba; Georg M Goerg; Laurent Hébert-Dufresne
Journal:  PLoS Comput Biol       Date:  2013-02-07       Impact factor: 4.475

9.  Optimizing treatment regimes to hinder antiviral resistance in influenza across time scales.

Authors:  Oscar Patterson-Lomba; Benjamin M Althouse; Georg M Goerg; Laurent Hébert-Dufresne
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

Review 10.  The Irrationality of GOF Avian Influenza Virus Research.

Authors:  Simon Wain-Hobson
Journal:  Front Public Health       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.